Frequently Asked Questions
What value is the market expected to touch by 2028?
The global pseudouridine market is expected to reach USD 49 million by 2028.
What CAGR is the market expected to exhibit by 2028?
The market is expected to exhibit a CAGR of 39.9% by 2028.
Which are the driving factors of the market?
Drivers of this market are emerging use of product to treat cancer and treatment of other diseases.
Which are the top companies operating in the market?
BOC Sciences, YAMASA, TriLink BioTechnologies (Maravai LifeSciences), Thermo Scientific Chemicals, Biosynth Carbosynth, Wuhan Glycogene, Ulcho Biochemical Ltd (FCAD Group), Shanghai Hongene Biotech, Wuhan Finetech, MP Biomedicals, and Toronto Research Chemical are key companies operating in the market.